Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -100.00% | -100.00% | -100.00% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -100.00% | -100.00% | -100.00% | -- |
| SG&A Expenses | -6.55% | -1.51% | -4.21% | -16.95% | -29.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.47% | 2.80% | 2.47% | -1.50% | -14.47% |
| Operating Income | -15.68% | -4.66% | -4.30% | -0.27% | 16.11% |
| Income Before Tax | -17.38% | -7.79% | -5.43% | -8.81% | 13.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.38% | -7.79% | -5.43% | -8.81% | 13.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.38% | -7.79% | -5.43% | -8.81% | 13.74% |
| EBIT | -15.68% | -4.66% | -4.30% | -0.27% | 16.11% |
| EBITDA | -15.69% | -4.69% | -4.32% | -0.26% | 16.12% |
| EPS Basic | 58.28% | 73.50% | 81.87% | 86.97% | 92.48% |
| Normalized Basic EPS | 57.69% | 72.99% | 80.71% | 86.56% | 92.41% |
| EPS Diluted | 58.28% | 73.53% | 81.89% | 86.97% | 92.49% |
| Normalized Diluted EPS | 57.69% | 72.99% | 80.71% | 86.56% | 92.41% |
| Average Basic Shares Outstanding | 210.37% | 210.46% | 244.62% | 360.77% | 679.73% |
| Average Diluted Shares Outstanding | 210.37% | 210.46% | 244.62% | 360.77% | 679.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |